KNR delivered yet again another robust quarterly performance. Kerala/Muzaffarpur BOT collection per day stood at Rs 1.8/2.2mn vs. Rs 1.9/2.7mn QoQ. KNR is in advance stage of selling Kerala BOT. For 3 HAM projects Rs 1.7bn investment, KNR expects to receive Rs 3.3bn over the next 4yrs. Strong balance sheet, periodic BOT/HAM equity churn and robust execution capability reinforces our positive stance on KNR. We maintain BUY. Key risks (1) Slowdown in government ordering (2) Higher crude and cement prices (3) Increase in interest rates and (4) Further liquidity tightening in the financial sector. We maintain BUY on KNR with SOTP-based TP of Rs 378/sh (valuing core EPC business 18x FY21EPS at Rs 319/sh, Subsidiaries Rs 60/sh). KNR delivered yet another robust quarter with Revenue/EBIDTA/APAT beat of 10/20/35% respectively.

PNC has been delivering robust performance for past 6-7qtrs as entire order backlog Rs 98.7bn (ex Rs 20bn Lucknow Ring Road and Karnataka HAM) has moved into execution. With Net D/E of 0.1x end 2QFY20, PNC is well placed to take up new HAM projects. Anticipating strong improvement PNC has increased fund/non-fund based limits to Rs 10/50bn. As NHAI bidding picks up PNC is well placed to bag new orders. NWC days has improved from 97days to 59 in 1HFY20. PNC is in talks with investors to sell under construction HAM portfolio. We maintain BUY. Key risks (1) Slowdown in NHAI ordering; (2) Delay in UP state projects awards. PNC has been delivering robust performance for past 6-7qtrs as entire order backlog Rs 98.7bn (ex Rs 20bn Lucknow Ring Road and Karnataka HAM) has moved into execution. With Net D/E of 0.1x end 2QFY20, PNC is well placed to take up new HAM projects. Anticipating strong improvement PNC has increased fund/non-fund based limits to Rs 10/50bn. As NHAI bidding picks up PNC is well placed to bag new orders. NWC days has improved from 97days to 59 in 1HFY20. PNC is in talks with investors to sell under construction HAM portfolio. We maintain BUY. Key risks (1) Slowdown in NHAI ordering; (2) Delay in UP state projects awards. PNC reported 2QFY20 Rev/EBIDTA/APAT beat of 13/12/5% respectively. We maintain BUY on PNC with a SOTP based TP of Rs 340/sh (18x FY21E EPS). We have cut our APAT estimate by 9/0.4% for FY20/21E to factor in high...

Although BRIT is underperforming other FMCG cos in the near-term, medium term opportunity makes the story attractive. We believe BRIT can successfully become a total snacking company as it has all the right ingredients i.e. brand strength, deep distribution, superior management execution and operating scale. Besides, we expect BRIT to continue gaining share in biscuits led by premiumisation and distribution expansion in Hindi belt. BRIT has reduced its ICD's to its group companies to <Rs 5bn vs. ~Rs 7bn in Mar-19. BRITs 2Q performance was soft and in-line (after miss in 1QYF20). Co has underperformed peers (HUL, Dabur etc) in 1HFY20 owing to slowdown in biscuit category growth. However, market share gains and promising new launches keeps us interested. We expect gradual recovery in 2HFY20. We cut estimates by ~2% to factor delay in full recovery (1Q onwards vs. 4Q earlier). We value BRIT at 45x P/E on Sep-21E EPS, arriving at a TP of Rs 3,513. Maintain BUY.

ONGC generates OCF yield of almost 28% and divided yield of 7.4% over FY20/21E. Despite realising market price for oil in the absence of any subsidy sharing, upstream companies have remained unfavourable. Stake sale from government to achieve its disinvestment targets remains a key overhang on the stock (in last 2 years GoI's shareholding shrunk from 68.02% to 62.98%). We maintain BUY with a TP of Rs 187/sh (8x Jun-21E standalone core EPS (adj. for dividend income) + OVL EPS and Rs 34 from other investments). Post an in line performance in Q2, we maintain BUY on ONGC. Adjusting for its investments (OVL+ other) the stock is trading at 5.8x Sep-21E standalone EPS. We believe that such pessimism is unwarranted.

Following the strong momentum in DXC over FY17-19 (22% CAGR), growth is now expected to be led by Direct Core supported by (1) Strong deal wins (15% QoQ), (2) Strategic accounts (double-digit growth & market share gains in BFS), (3) New logos (including F100 accounts) and (4) Blackstone channel (5% of Direct core). While we remain positive on Direct Core channel, we lower growth est for DXC-HP segment with increased risk around the new strategic roadmap for DXC (leadership change, business divestment, Virtual Clarity acquisition). Expect USD rev/EPS growth at 10% CAGR over FY19-22E. We maintain BUY on Mphasis following a nearly in-line 2Q. Growth drivers in Direct Core are intact, while DXC portfolio risk has increased. Our TP of Rs 1,140 values Mphasis at 16x Sep-21E EPS

AHLU delivered yet another 2QFY20 miss. We continue to remain patient as execution shall start on entire order backlog from 4QFY20E. About Rs 10.6bn worth of projects (15% of OB) are slow moving of this Rs 5.5bn Charbagh Station redevelopment may get foreclosed due to environment hurdle. New wins of Rs 20bn doesn't have environment concerns. Delhi construction ban may get lifted by Nov-19 end. The Robust balance sheet, net cash status and better than peers RoE/RoCE are other comforting factors. We maintain BUY. Key risks include (1) Slow down in government capex; (2) High cost inflation; (3) Stuck projects; (4) Lower than expected leasing in Kota BOT project. We maintain BUY on AHLU with a reduced TP of Rs 388 (vs. Rs 402/sh earlier) despite 26% 2QFY20 miss on APAT. We downgrade our FY20/21E EPS by (13)/2.7% to factor in slow order book to execution conversion and ~Rs 10.6bn of non moving projects. Tight liquidity is another factor impacting growth. We value the core EPC operations at 15x FY21E EPS.

DBL has established itself as strong executioner with a track record of securing early completion bonus for its projects, though it comes at a cost of inventory pile up and NWC stress in case of delays in Appointed Date. With all but one of its HAM projects awaiting AD, we expect an improvement in NWC situation. DBL has secured a deal for monetization of its HAM portfolio with Cube Highways, which may enable capital churning and help bid for new projects. We maintain BUY with a cautious approach on debt built up We maintain BUY on DBL, with a reduced TP of Rs 717/sh (vs. Rs 737/sh earlier). We retain our target EPC multiple at 12x FY21E EPS to factor a marginal cut in FY20 revenue estimates. We have revised our FY20/21 EPS estimates lower by 9.9/4.9% respectively.

Cloud revenue growth has witnessed slowdown in the last two quarters due to completion of a large project. The back-fill will happen gradually with new deal wins, go-lives and growth in subscription revenue. Partnership with Capgemini, IBM and Microsoft (Azure) looks promising but large deal wins are still not coming. We expect revenue CAGR of 10% over FY19-22E (cloud CAGR of 16%). We maintain our positive stance on Majesco based on (1) Rising adoption of third-party software by insurers, (2) Solid partnerships, (3) Continued deal wins, and (4) Cloud traction. The risk to our thesis includes slowdown in cloud deal wins, prolonged sales cycle and deterioration in US/Europe macros. We maintain BUY on Majesco despite poor 2QFY20. Revenue fall was led by cloud (completion of large implementation) but the fall in EBIT margin was lower than expected. The order backlog remains robust and cloud deal wins are healthy. We cut FY20/21E USD revenue est. by 4.1/5.4% to factor in 2Q miss. Our TP of Rs 677 implies EV/rev multiple of 2.0x on Sep FY21 rev.

Despite an encouraging quarter on collections and pre-sales, PEPL has seen further debt built up, posing a challenge for the management in achieving optimal leverage (target D/E of 1.4 by FY20E). One of the few positives is that ~64% of debt is backed either by annuity or by rental securitization/ bill discounting. Launches during 1HFY20 were largely tilted towards commercial projects (6.2mn sqft out of 7.9mn sqft). The company continues to look at opportunities for monetization of its retail/hospitality assets and update on the same (expected in 3QFY20) would provide a re-rating trigger. Retain NEU with Rs 297/sh TP. We maintain NEU on Prestige Estate (PEPL) despite pre-sales and collections holding steady, owing to increasing debt and limited visibility on asset monetization. Our SOTP based TP is Rs 297/sh. We have increased our FY20/21E EPS estimates by 16%/20% respectively.

ABB is well placed to benefit from capex led economic expansion. Government initiative on tax reduction augurs well over long term for developing India into a global manufacturing hub. India enjoys both domestic demand and labour arbitrage vs. global supply chain. Manufacturing shifts take time and near term weak economic outlook poses re-rating headwinds. We recommend NEU on ABB. Key risks (1) Delays in Government capex recovery, (2) Slowdown in private investments, (3) INR depreciation, and (4) Any adverse corporate action. We recommend NEU on ABB India Ltd. (ABB) with SOTP based TP of Rs 1,534/sh (42x ABB, 30x Power Grids discontinued business). Whilst ABB is well placed to cater to Automation/Motion/Electrical segments, demand headwinds and punchy valuation limits further re-rating. Strong balance sheet, Automation Products/Solutions expertise and cross cycles experience limits downside.

Inexplicably slow growth at REPCO, in the face of waning competition has disappointed for a while now. Availability of debt and ample CRAR (~25%) and liquidity are big positives, even though REPCO may not use this to grow much faster. At 1x FY21E ABV, our stance is mostly premised on inexpensive valuation. Slowing growth and stable asset quality in a qtr that usually sees seasonal improvement, disappointed. The tax cut boosted earnings. Maintain BUY with a TP of Rs 419 (1.5x Sept-21E ABV).

We remain constructive on the company given its diversified portfolio, healthy volume growth (9-10% over FY20-22E) and quality of customers. Robustness of its business enables GSL to maintain stable margins (EBITDAM of ~12.5 expected over FY20-22E). Given the secular growth opportunity and its capability to generate 20%+ returns on reinvested profits, GSL's current PER of 19.8/17.3x FY21/22E is rather low. We value GSL at 22x Sep-21 EPS to arrive at a TP of Rs 1,834. Maintain BUY. Galaxy Surfactants (GSL) 2QFY20 performance was commendable with >10% YoY volume growth amidst slowdown in the global Home and Personal care (HPC) market. GSL maintained a cautious domestic demand outlook for 2HFY20 but a gradual shift in consumption pattern towards specialty care products will help maintain profitability in the long run. Other geographies, however, will continue to support volume growth in 2H.

Maintain BUY as (1) SpiceJet will benefit from the improving industry structure in the medium term (2) Fuel prices remain benign, which will allow for better cost management (3) Further, any resolution with regards to the 737 MAX planes will improve the cost structure of the low cost carrier. The stock is trading at reasonable valuations of 9.6/6.7/5.9x EV/EBITDAR on FY20/21E/22E. SpiceJets 2QFY20 results were weaker than expected (Reported loss of Rs 4.6 bn) due to the adverse impact from the grounding of the 737 MAX planes as well as seasonality. We have lowered our EBITDAR estimates by ~ 15% over FY20-22 to factor in the above. Maintain BUY with a revised TP of Rs 140 (at 7x Sep-21E EV/EBITDAR).

Summer 2019 confirms our thesis that Symphony will deliver strong performance if summer is hot. Organised air cooler market (27/35% volume/value mix) will deliver 15% CAGR despite rising affluence towards RAC. Symphony's constant focus on product innovation and superior franchise with distributors will make the company competitive. With trade inventory now at low levels, Symphony will enjoy off-season stocking, opportunity to launch tech-rich coolers and benefit from a favorable base. Besides, its international performance will improve given the various initiatives undertaken. Symphony continued its strong momentum in 2Q after a sharp recovery in summer-19. 2Q performance was in-line with expectations and further builds our confidence for a robust 2HFY20 show. We remain bullish on Symphony given its sharp recovery in domestic biz and scope to tap new opportunities (industrial and commercial cooling, portable coolers in Aus and US). We maintain estimates and value Symphony at 45x Sep-21 EPS. We believe the stock will re-rate owing to consistent outperformance vs. appliance cos. We maintain BUY with TP of Rs 1,812.

VO has corrected 17% from its peak (Sep-19) and is trading at 22.8/19.4x FY21/22E PER. We believe it should command premium valuations owing to (1) Its impeccable product selection (2) High market share globally (3) Best in class return ratios and earnings trajectory. We upgrade VO to BUY despite muted performance in 2QFY20. VO will generate RoE of 30.5/27.1/24.8% and RoIC of 29.6/30.7/33.1% in FY20/21/22E. Valuations are contextually low at 22.8/19.4x FY21/22E PER. Our TP of Rs 2,331/share is based on a 25x Sep-21E EPS.

GICRE is India's largest reinsurer but continues to make high underwriting losses mainly in its foreign operations (1H:125%). We thus remain concerned of company's plans to increase foreign business. We estimate an FY22E adj. RoE of just 10.0%, and with stable growth we can at best assign a valuation of just 0.8x Sep-21E ABV. Given recent run up in price, we downgrade the stock to NEUTRAL with an unchanged TP of Rs 250 (0.8x Sep-21E ABV). GICREs 2QFY20 saw a NEP increase 7.5% YoY to Rs 118.6bn; COR (calc.) declined 208bps YoY to 125.1%. High COR in foreign operations is a concern, as GICRE failed yet again to meet its guidance of lower COR.

MGL did not win any new GAs in ninth or tenth rounds of CGD biddings. This factor may weigh on its long-term growth. Its loyal customer base of CNG and commercial establishments (who together comprise 81% of total sales mix), that are less price sensitive than industrial customers enable it to maintain per unit margins higher than peers. Moreover, we do not foresee any significant regulatory adversity in its CGD business either through a change in gas allocation or capping returns. We maintain BUY on MGL despite muted volume growth owing to its remarkable pricing power (hence, better spreads) and inexpensive valuations (14.5/13.7x FY21/22E PER) versus its peers (IGL 25.3/22.6x and GGL 16.2/14.2x). Our TP is Rs 1,355/sh (19x Sep-21E EPS).

We estimate the co to deliver consolidated EBITDA/PAT CAGR of 22/35% during FY19-22E. We reiterate BUY with a higher TP of Rs 1,523 as we value its consol Sep'21E EBITDA at 10x and ascribe 50% value to its FY21/22E CWIP. The stock trades at attractive valuations of 9.0/8.4x FY21/22E EBIITDA and at EV of USD 100/MT. We reiterate BUY on JK Cement (JKCE) with a TP of Rs 1,523 (10x Sep21 consol EBITDA), implying EV USD 115/MT. We continue to like the co for its strengthening capability and strong presence in white/putty segment.

Despite a weak 2Q results, we like DCL for its strong margin focus and increasing cost reduction measures. We expect demand recovery in 2H to boost profitability and internal accruals for growth capex. We maintain BUY with TP Rs 610/share (6x Sep'21E EBITDA and 50% value to its FY22E CWIP). Our TP implies EV of USD 56/MT. The stock currently trades at 4.0/4.7x FY21/22E EBITDA and EV of USD 41/MT. We maintain BUY with TP Rs 610 (6x Sep21E EBITDA and 50% val to FY22E CWIP). Our TP implies EV of USD 56/MT.

We are NEUTRAL on RK Forgings (1) While the CV segment outlook is mixed, diversification initiatives will de-risk the business model. The expected acquisition of ACIL will provide access to tractor/2W customers (2) The co is sustaining market share in the domestic segment, amidst a sedate demand environment. In 2QFY20, RK Forgings EBITDA margin at 18.1% (-90bps YoY) continued to be impacted by a weak demand environment. The co is diversifying beyond CVs through expansion into new segments/inorganic initiatives. We recently upgraded the stock to NEUTRAL post the sharp stock correction and the risk-reward is more favourable. We are lowering estimates by ~2% and set a revised TP of Rs 275 (@12x Sep-21 EPS).